ConductScience.org, home
MUSK: muscle associated receptor tyrosine kinase
API referenceFor AI assistants

Gene · 4593

Papers3,141

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

21 to 40 of 3,141

Download this page as JSON
TitleJournalYearPMIDFound bySource
Rituximab in AChR and MusK Myasthenia Gravis: long-term follow-up with different therapeutic protocols.J Neurol Sci202642492144PubTator, text miningPubMed
Improving sensitivity of autoantibody testing for myasthenia gravis using cell-based assays: an evaluation of strategies that may be used in clinical practice.Front Neurol202642491105PubTator, text miningPubMed
Very late-onset myasthenia gravis: a systematic review and meta-analysis of sex distribution, thymic pathology and autoantibodies.J Neurol202642461294PubTator, text miningPubMed
Correction to: IgA autoantibodies demonstrate a novel mechanism of MuSK myasthenia gravis pathology.Brain202642440080PubTator, text miningPubMed
Retraction: Aseptic Meningitis Following Rozanolixizumab in a Patient With Refractory Anti-MuSK Positive Myasthenia Gravis: A Case Report.Neurohospitalist202642422757PubTator, text miningPubMed
Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.Neurology202642407020PubTator, text miningPubMed
MuSK antibodies differently affect the MuSK signaling cascade depending on valency and epitope specificity.J Autoimmun202642391746PubTator, text miningPubMed
Muscle-Specific Kinase Signaling and Its Therapeutic Potential.Muscle Nerve202642387809PubTator, text miningPubMed
AGRN-, LRP4-, MUSK-Related CMS: Clinical, Neurophysiological, Morphological, Genetic and Pathological Mechanisms.Muscle Nerve202642383531PubTator, text miningPubMed
IgG Subclass (IgG1-4) and IgA Autoantibody Profiles Against Muscle-Specific Kinase in a Greek Cohort.Muscle Nerve202642378014PubTator, text miningPubMed
Steroid-Sparing Effect of Efgartigimod in Generalized Myasthenia Gravis: Study Protocol for a Single-Arm, Open-Label Clinical Trial.Neurol Ther202642371330PubTator, text miningPubMed
Health-related quality of life outcomes with nipocalimab versus placebo in generalized myasthenia gravis: an analysis of the Vivacity-MG3 study.J Neurol202642360473PubTator, text miningPubMed
Ofatumumab in refractory anti-muscle-specific tyrosine kinase antibody-positive myasthenia gravis: a case report of successful salvage therapy and mechanistic insights.Front Immunol202642358945PubTator, text miningPubMed
Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives.Front Neurol202642358938PubTator, text miningPubMed
Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.Brain202642334385PubTator, text miningPubMed
Myasthenia gravis misdiagnosis in the era of innovative therapies: Uncovering pitfalls and patterns.J Neuroimmunol202642330780PubTator, text miningPubMed
Magnesium Sulfate-Induced Myasthenic Crisis in Pregnancy: A Case Report.Cureus202642306025PubTator, text miningPubMed
Refractory Pembrolizumab-Induced Myocarditis-Myositis-Myasthenia Gravis Overlap Syndrome With Concurrent Hepatitis and Thyroiditis in Endometrial Carcinoma: A Case Report.Cureus202642261457PubTator, text miningPubMed
An S752D activation loop mutation dynamically primes Muscle-Specific Kinase for activation.Biochem J202642240394PubTator, text miningPubMed
Development of the first myasthenia gravis patient registry in Latvia: a single-centre experience.Sci Rep202642218175PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4593/papers?page=2

API referenceFor AI assistants